Find uplifting stories about heroes, innovations, and solutions
9782 results for "nhs breakthrough"
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
Around 20 people in England with a debilitating genetic condition can now access the first treatment that targets the root cause of their disease. The NHS will provide pegzilarginase to patients with arginase-1 deficiency after breakthrough approval.
A groundbreaking combination treatment for lupus nephritis just won approval in England, offering 12,000 people with kidney damage a real shot at restored health. The therapy works twice as well as current options at bringing kidney function back to normal.
A breakthrough cream that targets the root cause of vitiligo will now be available free through England's NHS, offering hope to people living with the skin condition. The treatment has shown remarkable results in restoring skin pigmentation for thousands who previously had limited options.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer. Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.
Nearly 30,000 people in England with chronic lung disease will gain access to the first treatment that targets an underlying cause, not just symptoms. The twice-monthly injection cuts severe flare-ups by 30% and could save the NHS millions.
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
A new one-minute cancer treatment is replacing two-hour hospital sessions for 14,000 patients across England. The breakthrough immunotherapy injection frees patients to live their lives while helping the NHS treat more people faster.
Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years. The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.
After two decades, women with hard-to-treat ovarian cancer finally have a new option. The targeted therapy offers more precious time with loved ones and dramatically fewer side effects than traditional chemotherapy.
Chinese researchers have perfected a way to bond two critical fusion reactor materials, bringing us closer to clean, unlimited energy. The breakthrough solves a major engineering challenge that has limited fusion reactor development.
A new NHS pilot uses AI and robotic catheters to diagnose lung cancer in a single appointment instead of weeks of anxious waiting. The technology has already helped 215 patients start cancer treatment faster.
A groundbreaking NHS study using data from 29 million people reveals how secure health monitoring can spot disease trends early and help fix care gaps. The research shows chronic kidney disease diagnoses jumped 35% above expected levels, likely due to better testing and new treatments.
The NHS is creating the world's first national database of 120 cancer-linked genes, offering free genetic testing and early screening to tens of thousands of families. It's a game-changing shift from treating cancer to preventing it before it starts.
A breakthrough ovarian cancer treatment now available on the NHS extends patient lives by nearly four months while dramatically reducing side effects. Women can now keep their hair, enjoy family gatherings, and live fuller lives during treatment.
Women in England who can't take hormone replacement therapy now have access to a groundbreaking pill that dramatically reduces hot flushes and night sweats. The move brings relief to half a million women whose options were previously limited.
UK cancer patients can now receive three chemotherapy cycles instead of six without compromising survival, following groundbreaking research that prioritizes quality of life. The NHS has already updated its treatment guidelines to offer this less toxic option.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
Scientists developed an AI tool that identifies advanced bowel cancer patients unlikely to respond to a recently approved NHS drug, potentially sparing thousands from ineffective treatment and serious side effects. The breakthrough could personalize care and guide patients toward therapies that actually work for them.
Showing 20 of 9782